Summit Global Investments »

iShares Dow Jones US Pharm Indx shares owned by Summit Global Investments

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $583k 6.7k 86.64

More positions owned by Summit Global Investments

RBB Sgi Enhanced Cor (USDX)
RBB Sgi Enhanced Mkt (LDRX)
RBB Sgi Us Large Cap (SGLC)
RBB Sgi Diversi Tac (DYTA)
RBB Sgi Enhanced Glb (GINX)
RBB Sgi Enhanced Nas (QXQ)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Spdr Index Shs Fds State Street Spd (SPDW)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)

View all positions for Summit Global Investments

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Foundations Investment Advisors
Morgan Stanley
Bank of America Corporation
Aptus Capital Advisors
McElhenny Sheffield Capital Management
LPL Financial
Anfield Capital Management
Insight Wealth Strategies
Royal Bank of Canada
Cetera Investment Advisers
Prevail Innovative Wealth Advisors
Goldman Sachs Group
Virtue Capital Management
Brown Advisory Holdings Incorporated

View all funds holding iShares Dow Jones US Pharm Indx